摘要
阿尔茨海默病(AD)是世界上最常见的痴呆症。尽管它的发现和病理表现集中于淀粉样蛋白- β (a β)和tau蛋白的过度磷酸化,但在过去的十年中,神经炎症已经成为该疾病的发病机制和进展的主要组成部分。小胶质细胞作为中枢神经系统(CNS)中主要的先天免疫细胞类型,在调节神经炎症中发挥着非常重要的作用,神经炎症常见于神经退行性疾病,包括AD。在炎症反应下,小胶质细胞发生形态变化,从稳态状态转变为激活状态。在AD中,不同的小胶质细胞亚型表现出不同的遗传特征,这些特征通常与从全基因组关联研究(GWAS)中识别出的AD风险基因有关,如APOE和TREM2。此外,许多AD风险基因在小胶质细胞中高度富集,并特异性影响小胶质细胞在发病过程中的功能,如释放炎症细胞因子和清除Aβ。因此,基于目前的临床前研究以及它们的致病或保护作用,建立小胶质细胞中这些风险基因的景观,将在很大程度上帮助我们理解AD复杂的病因,并为有效治疗的未满足的需求提供新的见解。
关键词: 阿尔茨海默病,小胶质细胞,神经炎症,AD风险基因,APOE, GWAS。
Current Alzheimer Research
Title:Microglia and its Genetics in Alzheimer's Disease
Volume: 18 Issue: 9
关键词: 阿尔茨海默病,小胶质细胞,神经炎症,AD风险基因,APOE, GWAS。
摘要: Alzheimer’s Disease (AD) is the most prevalent form of dementia across the world. While its discovery and pathological manifestations are centered on protein aggregations of amyloid- beta (Aβ) and hyperphosphorylated tau protein, neuroinflammation has emerged in the last decade as a main component of the disease in terms of both pathogenesis and progression. As the main innate immune cell type in the central nervous system (CNS), microglia play a very important role in regulating neuroinflammation, which occurs commonly in neurodegenerative conditions, including AD. Under inflammatory response, microglia undergo morphological changes and status transition from homeostatic to activated forms. Different microglia subtypes displaying distinct genetic profiles have been identified in AD, and these signatures often link to AD risk genes identified from the genome-wide association studies (GWAS), such as APOE and TREM2. Furthermore, many AD risk genes are highly enriched in microglia and specifically influence the functions of microglia in pathogenesis, e.g. releasing inflammatory cytokines and clearing Aβ. Therefore, building up a landscape of these risk genes in microglia, based on current preclinical studies and in the context of their pathogenic or protective effects, would largely help us to understand the complex etiology of AD and provide new insight into the unmet need for effective treatment.
Export Options
About this article
Cite this article as:
Microglia and its Genetics in Alzheimer's Disease, Current Alzheimer Research 2021; 18 (9) . https://dx.doi.org/10.2174/1567205018666211105140732
DOI https://dx.doi.org/10.2174/1567205018666211105140732 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
Call for Papers in Thematic Issues
Current updates on the Role of Neuroinflammation in Neurodegenerative Disorders
Neuroinflammation is an invariable hallmark of chronic and acute neurodegenerative disorders and has long been considered a potential drug target for Alzheimer?s disease (AD) and dementia. Significant evidence of inflammatory processes as a feature of AD is provided by the presence of inflammatory markers in plasma, CSF and postmortem brain ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Neurotransmitters and Microglial-Mediated Neuroinflammation
Current Protein & Peptide Science Targeting NO/cGMP Signaling in the CNS for Neurodegeneration and Alzheimer’s Disease
Current Medicinal Chemistry On the Relationship Between the Light/Dark Cycle, Melatonin and Oxidative Stress
Current Pharmaceutical Design PPARs in Neurodegenerative and Neuroinflammatory Pathways
Current Alzheimer Research Overview of PCTK3/CDK18: A Cyclin-Dependent Kinase Involved in Specific Functions in Post-Mitotic Cells
Current Medicinal Chemistry Natural Animal Models of Neurodegenerative Protein Misfolding Diseases
Current Pharmaceutical Design Role of Nuclear Factor Kappa B (NF-κB) Signalling in Neurodegenerative Diseases: An Mechanistic Approach
Current Neuropharmacology Are Catechins, Polyphenols in Tea, Good for Your Health?
Current Nutrition & Food Science State of the Art Clinical Efficacy and Safety Evaluation of N-Acetylcarnosine Dipeptide Ophthalmic Prodrug. Principles for the Delivery, Self-Bioactivation, Molecular Targets and Interaction with a Highly Evolved Histidyl-Hydrazide Structure in the Treatment and Therapeutic Management of a Group of Sight-Threatening Eye Diseases
Current Clinical Pharmacology Relevance of Follow-Up in Patients with Core Clinical Criteria for Alzheimer Disease and Normal CSF Biomarkers
Current Alzheimer Research Exploring Multiple Sclerosis (MS) and Amyotrophic Lateral Scler osis (ALS) as Neurodegenerative Diseases and their Treatments: A Review Study
Current Topics in Medicinal Chemistry Molecular Dynamics and Regulation of Butyrylcholinesterase Cholinergic Activity by RNA Binding Proteins
CNS & Neurological Disorders - Drug Targets Exploring Molecular Approaches in Amyotrophic Lateral Sclerosis: Drug Targets from Clinical and Pre-Clinical Findings
Current Molecular Pharmacology Redox Signaling Pathways Involved in Neuronal Ischemic Preconditioning
Current Neuropharmacology Withdrawn: Mesenchymal Stem Cell-derived Exosomes for Treatment of Ischemic Stroke
Current Stem Cell Research & Therapy miRNAs in Alzheimer Disease – A Therapeutic Perspective
Current Alzheimer Research Resveratrol and Lifespan in Model Organisms
Current Medicinal Chemistry Review on Patents for Ubiquitin-Proteasome Inhibitor as Medical Advance in Major Human Diseases
Recent Patents on Biomedical Engineering (Discontinued) Activity-dependent Synaptic Plasticity and Metaplasticity in Spinal Motor Networks
Current Pharmaceutical Design Insect Peptides – Perspectives in Human Diseases Treatment
Current Medicinal Chemistry